| C | Sektion C — Chemie; Hüttenwesen | SECTION C — CHEMISTRY; METALLURGY |
| C07 | Organische Chemie (Verbindungen wie Oxide, Sulfide oder Oxysulfide des Kohlenstoffs, Cyan, Phosgen, Cyanwasserstoffsäure oder deren Salze C01; Erzeugnisse, erhalten aus basenaustauschenden Schichtsilicaten durch Ionenaustausch mit organischen Verbindungen wie Aluminium-, Phosphonium- oder Sulfoniumverbindungen oder durch Interkalation organischer Verbindungen C01B 33/44; makromolekulare Verbindungen C08; Farbstoffe C09; Gärungserzeugnisse C12; Gärungsverfahren oder Verfahren unter Verwendung von Enzymen zur gezielten Synthese von chemischen Verbindungen oder Zusammensetzungen oder zur Trennung optischer Isomerer aus einer racemischen Mischung C12P; Herstellung organischer Verbindungen durch Elektrolyse oder Elektrophorese C25B 3/00 , C25B 7/00) [2] | ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds C01B 33/44; macromolecular compounds C08; dyes C09; fermentation products C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture C12P; production of organic compounds by electrolysis or electrophoresis C25B 3/00, C25B 7/00) [2] |
| C07K | Peptide (β -Lactamringe enthaltende Peptide C07D; cyclische Dipeptide, die in ihrem Molekül keine andere Peptidbindung enthalten außer denen, die den Ring bilden, z.B. Piperazin-2,5-dione, C07D; Ergotalkaloide vom Peptid-Typ C07D 519/02; Einzellerproteine, Enzyme C12N; genetische Verfahrenstechnik zur Gewinnung von Peptiden C12N 15/00) [4] | PEPTIDES (peptides containing β-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00) [4] |
| C07K 1/00 | Allgemeine Verfahren zur Herstellung von Peptiden [4] | General processes for the preparation of peptides [4] |
| C07K 1/02 | | |
| C07K 1/04 | | |
| C07K 1/06 | . | unter Verwendung von Schutzgruppen oder Aktivierungsreagenzien [4] |
| . | using protecting groups or activating agents [4] |
|
| C07K 1/08 | . . | unter Verwendung von Aktivierungsreagenzien [4] |
| . . | using activating agents [4] |
|
| C07K 1/10 | . | unter Verwendung von Kupplungsreagenzien [4] |
| . | using coupling agents [4] |
|
| C07K 1/107 | . | durch chemische Modifikation von Vorläuferpeptiden [6] |
| . | by chemical modification of precursor peptides [6] |
|
| C07K 1/113 | . . | ohne Änderung der Primärstruktur [6] |
| . . | without change of the primary structure [6] |
|
| C07K 1/12 | | |
| C07K 1/13 | . | Markierung von Peptiden [6] |
| . | Labelling of peptides [6] |
|
| C07K 1/14 | . | Extraktion; Abtrennung; Reinigung [4, 6] |
| . | Extraction; Separation; Purification [4, 6] |
|
| C07K 1/16 | . . | durch Chromatografie [6] |
| . . | by chromatography [6] |
|
| C07K 1/18 | . . . | Ionenaustausch-Chromatografie [6] |
| . . . | Ion-exchange chromatography [6] |
|
| C07K 1/20 | . . . | Verteilungs-, Umkehrphasen- oder hydrophobe Wechselwirkungschromatografie [6] |
| . . . | Partition-, reverse-phase or hydrophobic interaction chromatography [6] |
|
| C07K 1/22 | . . . | Affinitätschromatografie oder verwandte Techniken basierend auf selektiven Absorptionsverfahren [6] |
| . . . | Affinity chromatography or related techniques based upon selective absorption processes [6] |
|
| C07K 1/24 | . . | durch elektrochemische Mittel [6] |
| . . | by electrochemical means [6] |
|
| C07K 1/26 | | . . . | Electrophoresis [6] |
|
| C07K 1/28 | . . . . | isoelektrische Fokussierung [6] |
| . . . . | Isoelectric focusing [6] |
|
| C07K 1/30 | | |
| C07K 1/32 | | |
| C07K 1/34 | . . | durch Filtration, Ultrafiltration oder Umkehrosmose [6] |
| . . | by filtration, ultrafiltration or reverse osmosis [6] |
|
| C07K 1/36 | . . | durch eine Kombination von zwei oder mehr Verfahren verschiedener Art [6] |
| . . | by a combination of two or more processes of different types [6] |
|
| C07K 2/00 | Peptide mit unbestimmter Anzahl an Aminosäuren; Derivate davon [6] | Peptides of undefined number of amino acids; Derivatives thereof [6] |
| C07K 4/00 | Peptide mit bis zu 20 Aminosäuren in undefinierter oder nur teilweise definierter Sequenz; Derivate davon [6] | Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof [6] |
| C07K 4/02 | | |
| C07K 4/04 | | |
| C07K 4/06 | | |
| C07K 4/08 | . | aus Algen; aus Flechten [6] |
| . | from algae; from lichens [6] |
|
| C07K 4/10 | | |
| C07K 4/12 | . | aus Tieren; aus Menschen [6] |
| . | from animals; from humans [6] |
|
| C07K 5/00 | Peptide mit bis zu 4 Aminosäuren in vollständig definierter Sequenz; Derivate davon [4] | Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof [4] |
| C07K 5/02 | . | mindestens eine abnormale Peptidbindung enthaltend [4] |
| . | containing at least one abnormal peptide link [4] |
|
| C07K 5/023 | . . | bei der mindestens eine β -Aminosäure beteiligt ist [6] |
| . . | in which at least a beta-amino acid is involved [6] |
|
| C07K 5/027 | . . | bei der mindestens eine gamma-Aminosäure beteiligt ist, z.B. Statin [6] |
| . . | in which at least a gamma-amino acid is involved, e.g. statine [6] |
|
| C07K 5/03 | . . | bei der mindestens eine delat-Aminosäure, z.B. eine isostere Aminosäure beteiligt ist [6] |
| . . | in which at least a delta-amino acid is involved, e.g. isosteres [6] |
|
| C07K 5/033 | . . | bei der mindestens eine epsilon- oder zeta-Aminosäure beteiligt ist [6] |
| . . | in which at least an epsilon- or zeta-amino acid is involved [6] |
|
| C07K 5/037 | . . | durch die Seitenkette einer α -Aminosäure gebildete, abnormale Bindung, z.B. gamma-Glu, epsilon-Lys, Glutathion [6] |
| . . | the abnormal link being formed by the side chain of an alpha-amino acid, e.g. gamma-Glu, epsilon-Lys, glutathione [6] |
|
| C07K 5/04 | . | nur normale Peptidbindungen enthaltend [4] |
| . | containing only normal peptide links [4] |
|
| C07K 5/06 | | |
| C07K 5/062 | . . . | mit einer acyclischen Seitenkette der ersten Aminosäure, z.B. Gly, Ala [6] |
| . . . | the side chain of the first amino acid being acyclic, e.g. Gly, Ala [6] |
|
| C07K 5/065 | . . . | mit einer carbocyclische Ringe enthaltenden Seitenkette der ersten Aminosäure, z.B. Phe, Tyr [6] |
| . . . | the side chain of the first amino acid containing carbocyclic rings, e.g. Phe, Tyr [6] |
|
| C07K 5/068 | . . . | mit einer mehr Aminogruppen als Carboxylgruppen enthaltenden Seitenkette der ersten Aminosäure, oder Derivate davon, z.B. Lys, Arg [6] |
| . . . | the side chain of the first amino acid containing more amino groups than carboxyl groups, or derivatives thereof, e.g. Lys, Arg [6] |
|
| C07K 5/072 | . . . | mit einer mehr Carboxylgruppen als Aminogruppen enthaltenden Seitenkette der ersten Aminosäure, oder Derivate davon, z.B. Asp, Glu, Asn [6] |
| . . . | the side chain of the first amino acid containing more carboxyl groups than amino groups, or derivatives thereof, e.g. Asp, Glu, Asn [6] |
|
| C07K 5/075 | . . . . | Asp-Phe; Derivate davon, z.B. Aspartam [6] |
| . . . . | Asp-Phe; Derivatives thereof, e.g. aspartame [6] |
|
| C07K 5/078 | . . . | mit einer heterocyclischen ersten Aminosäure, z.B. Pro, His, Trp [6] |
| . . . | the first amino acid being heterocyclic, e.g. Pro, His, Trp [6] |
|
| C07K 5/08 | | |
| C07K 5/083 | . . . | mit einer acyclischen Seitenkette der ersten Aminosäure, z.B. Gly, Ala [6] |
| . . . | the side chain of the first amino acid being acyclic, e.g. Gly, Ala [6] |
|
| C07K 5/087 | . . . | mit einer carbocyclische Ringe enthaltenden Seitenkette der ersten Aminosäure, z.B. Phe, Tyr [6] |
| . . . | the side chain of the first amino acid containing carbocyclic rings, e.g. Phe, Tyr [6] |
|
| C07K 5/09 | . . . | mit einer mehr Aminogruppen als Carboxylgruppen enthaltenden Seitenkette der ersten Aminosäure, oder Derivate davon, z.B. Lys, Arg [6] |
| . . . | the side chain of the first amino acid containing more amino groups than carboxyl groups, or derivatives thereof, e.g. Lys, Arg [6] |
|
| C07K 5/093 | . . . | mit einer mehr Carboxylgruppen als Aminogruppen enthaltenden Seitenkette der ersten Aminosäure, oder Derivate davon, z.B. Asp, Glu, Asn [6] |
| . . . | the side chain of the first amino acid containing more carboxyl groups than amino groups, or derivatives thereof, e.g. Asp, Glu, Asn [6] |
|
| C07K 5/097 | . . . | mit einer heterocyclischen ersten Aminosäure, z.B. Pro, His, Trp, z.B. Thyroliberin, Melanostatin [6] |
| . . . | the first amino acid being heterocyclic, e.g. Pro, His, Trp, e.g. thyroliberin, melanostatin [6] |
|
| C07K 5/10 | | |
| C07K 5/103 | . . . | mit einer acyclischen Seitenkette der ersten Aminosäure, z.B. Gly, Ala [6] |
| . . . | the side chain of the first amino acid being acyclic, e.g. Gly, Ala [6] |
|
| C07K 5/107 | . . . | mit einer carbocyclische Ringe enthaltenden Seitenkette der ersten Aminosäure, z.B. Phe, Tyr [6] |
| . . . | the side chain of the first amino acid containing carbocyclic rings, e.g. Phe, Tyr [6] |
|
| C07K 5/11 | . . . | mit einer mehr Aminogruppen als Carboxygruppen enthaltenden Seitenkette der ersten Aminosäure, oder Derivate davon, z.B. Lys, Arg [6] |
| . . . | the side chain of the first amino acid containing more amino groups than carboxyl groups, or derivatives thereof, e.g. Lys, Arg [6] |
|
| C07K 5/113 | . . . | mit einer mehr Carboxylgruppen als Aminogruppen enthaltenden Seitenkette der ersten Aminosäure, oder Derivate davon, z.B. Asp, Glu, Asn [6] |
| . . . | the side chain of the first amino acid containing more carboxyl groups than amino groups, or derivatives thereof, e.g. Asp, Glu, Asn [6] |
|
| C07K 5/117 | . . . | mit einer heterocyclischen ersten Aminosäure, z.B. Pro, His, Trp [6] |
| . . . | the first amino acid being heterocyclic, e.g. Pro, His, Trp [6] |
|
| C07K 5/12 | . . | Cyclische Peptide [4] |
| |
| C07K 7/00 | Peptide mit 5 bis 20 Aminosäuren in einer vollständig definierten Sequenz; Derivate davon [4, 6] | Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof [4, 6] |
| C07K 7/02 | . | lineare Peptide, die mindestens eine abnormale Peptidbindung enthalten [4] |
| . | Linear peptides containing at least one abnormal peptide link [4] |
|
| C07K 7/04 | . | lineare Peptide, die nur normale Peptidbindungen enthalten [4] |
| . | Linear peptides containing only normal peptide links [4] |
|
| C07K 7/06 | . . | mit 5 bis 11 Aminosäuren [4] |
| . . | having 5 to 11 amino acids [4] |
|
| C07K 7/08 | . . | mit 12 bis 20 Aminosäuren [4, 6] |
| . . | having 12 to 20 amino acids [4, 6] |
|
| C07K 7/14 | . . | Angiotensine; verwandte Peptide [4] |
| . . | Angiotensins; Related peptides [4] |
|
| C07K 7/16 | . . | Oxytocine; Vasopressine; verwandte Peptide [4] |
| . . | Oxytocins; Vasopressins; Related peptides [4] |
|
| C07K 7/18 | . . | Kallidine; Bradykinine; verwandte Peptide [4] |
| . . | Kallidins; Bradykinins; Related peptides [4] |
|
| C07K 7/22 | . . | Eledoisine; verwandte Peptide [4] |
| . . | Eledoisins; Related peptides [4] |
|
| C07K 7/23 | . . | luteinisierendes Hormon-freisetzendes Hormon [luteinising hormon-releasing hormon = LH-RH] [Gonadoliberin]; verwandte Peptide [6] |
| . . | Luteinising hormone-releasing hormone (LHRH); Related peptides [6] |
|
| C07K 7/28 | . . | Gramicidine A, B, D; verwandte Peptide [4] |
| . . | Gramicidins A, B, D; Related peptides [4] |
|
| C07K 7/50 | . | cyclische Peptide, die mindestens eine abnormale Peptidbindung enthalten [4] |
| . | Cyclic peptides containing at least one abnormal peptide link [4] |
|
| C07K 7/52 | . . | mit nur normalen Peptidbindungen im Ring [4] |
| . . | with only normal peptide links in the ring [4] |
|
| C07K 7/54 | . . | mit mindestens einer abnormalen Peptidbindung im Ring [4] |
| . . | with at least one abnormal peptide link in the ring [4] |
|
| C07K 7/56 | . . . | Ringschluss nicht über 2,4- Diaminobuttersäure [4] |
| . . . | the cyclisation not occurring through 2,4-diamino-butanoic acid [4] |
|
| C07K 7/58 | . . . . | Bacitracine; verwandte Peptide [4] |
| . . . . | Bacitracins; Related peptides [4] |
|
| C07K 7/60 | . . . | Ringschluss über die 4-Aminogruppe der 2,4- Diaminobuttersäure [4] |
| . . . | the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid [4] |
|
| C07K 7/62 | . . . . | Polymyxine; verwandte Peptide [4] |
| . . . . | Polymyxins; Related peptides [4] |
|
| C07K 7/64 | . | cyclische Peptide, die nur normale Peptidbindungen enthalten [4] |
| . | Cyclic peptides containing only normal peptide links [4] |
|
| C07K 7/66 | . . | Gramicidine S, C; Tyrocidine A, B, C; verwandte Peptide [4] |
| . . | Gramicidins S, C; Tyrocidins A, B, C; Related peptides [4] |
|
| C07K 9/00 | Peptide mit bis zu 20 Aminosäuren in einer vollständig definierten Sequenz, Saccharidreste enthaltend; Derivate davon [4, 6] | Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof [4, 6] |
| C07K 11/00 | Depsipeptide mit bis zu 20 Aminosäuren in einer vollständig definierten Sequenz; Derivate davon [4, 6] | Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof [4, 6] |
| C07K 11/02 | . | cyclisch, z.B. Valinomycine [4] |
| . | cyclic, e.g. valinomycins [4] |
|
| C07K 14/00 | Peptide mit mehr als 20 Aminosäuren; Gastrine; Somatostatine; Melanotropine; Derivate davon [6] | Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof [6] |
| C07K 14/005 | | |
| C07K 14/01 | | |
| C07K 14/015 | . . . | Parvoviridae, z.B. feliner Panleukopenia-Virus, menschlicher Parvo-Virus [6] |
| . . . | Parvoviridae, e.g. feline panleukopenia virus, human parvovirus [6] |
|
| C07K 14/02 | . . . | Hepadnaviridae, z.B. Hepatitis-B-Virus [6] |
| . . . | Hepadnaviridae, e.g. hepatitis B virus [6] |
|
| C07K 14/025 | . . . | Papovaviridae, z.B. Papilloma-Virus, Polyoma-Virus, SV40, BK-Virus, JC-Virus [6] |
| . . . | Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus [6] |
|
| C07K 14/03 | . . . | Herpetoviridae, z.B. Pseudotollwut-Virus [6] |
| . . . | Herpetoviridae, e.g. pseudorabies virus [6] |
|
| C07K 14/035 | . . . . | Herpes-simplex-Virus I oder II [6] |
| . . . . | Herpes simplex virus I or II [6] |
|
| C07K 14/04 | . . . . | Varicella-Zoster-Virus [6] |
| . . . . | Varicella-zoster virus [6] |
|
| C07K 14/045 | . . . . | Cytomegalo-Virus [6] |
| . . . . | Cytomegalovirus [6] |
|
| C07K 14/05 | . . . . | Eppstein-Barr-Virus [6] |
| . . . . | Epstein-Barr virus [6] |
|
| C07K 14/055 | . . . . | Virus der Marek'schen Krankheit [6] |
| . . . . | Marek's disease virus [6] |
|
| C07K 14/06 | . . . . | infektiöser boviner Rhinotracheitis-Virus [6] |
| . . . . | Infectious bovine rhinotracheitis virus [6] |
|
| C07K 14/065 | . . . | Poxviridae, z.B. Avipox-Virus [6] |
| . . . | Poxviridae, e.g. avipoxvirus [6] |
|
| C07K 14/07 | . . . . | Vaccinia-Virus; Variola-Virus [6] |
| . . . . | Vaccinia virus; Variola virus [6] |
|
| C07K 14/075 | | |
| C07K 14/08 | | |
| C07K 14/085 | . . . | Picornaviridae, z.B. Coxsackie-Virus, Echo-Virus, Entero-Virus [6] |
| . . . | Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus [6] |
|
| C07K 14/09 | . . . . | Virus der Maul- und Klauenseuche [6] |
| . . . . | Foot-and-mouth disease virus [6] |
|
| C07K 14/095 | | |
| C07K 14/10 | . . . . | Hepatitis-A-Virus [6] |
| . . . . | Hepatitis A virus [6] |
|
| C07K 14/105 | | |
| C07K 14/11 | . . . | Orthomyxoviridae, z.B. Influenza-Virus [6] |
| . . . | Orthomyxoviridae, e.g. influenza virus [6] |
|
| C07K 14/115 | . . . | Paramyxoviridae, z.B. Parainfluenza-Virus [6] |
| . . . | Paramyxoviridae, e.g. parainfluenza virus [6] |
|
| C07K 14/12 | . . . . | Mumps-Virus; Masern-Virus [6] |
| . . . . | Mumps virus; Measles virus [6] |
|
| C07K 14/125 | . . . . | Virus der Newcastle-Krankheit [6] |
| . . . . | Newcastle disease virus [6] |
|
| C07K 14/13 | . . . . | Hundestaupe-Virus [6] |
| . . . . | Canine distemper virus [6] |
|
| C07K 14/135 | . . . . | Respiratory-Syncytial-Virus [6] |
| . . . . | Respiratory syncytial virus [6] |
|
| C07K 14/14 | . . . | Reoviridae, z.B. Rota-Virus, Bluetongue-Virus, Colorado-Tick-Fieber-Virus [6] |
| . . . | Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus [6] |
|
| C07K 14/145 | . . . | Rhabdoviridae, z.B. Tollwut-Virus, Duvenhage-Virus, Mokda-Virus, vesikulärer Stomatitis-Virus [6] |
| . . . | Rhabdoviridae, e.g. rabies virus, Duvenhage virus, Mokda virus, vesicular stomatitis virus [6] |
|
| C07K 14/15 | . . . | Retroviridae, z.B. boviner Leukämie-Virus, feliner Leukämie-Virus, menschlicher T-Zell-Leukämie-Lymphoma-Virus [6] |
| . . . | Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus [6] |
|
| C07K 14/155 | . . . . | Lentiviridae, z.B. menschlicher Immunschwäche-Virus [HIV], Visna-maedi-Virus, Pferde-infektiöser Anämie-Virus [6] |
| . . . . | Lentiviridae, e.g. human immunodeficiency virus (HIV), visna-maedi virus, equine infectious anaemia virus [6] |
|
| C07K 14/16 | | |
| C07K 14/165 | . . . | Coronaviridae, z.B. Vogel-infektiöser Bronchitis-Virus [6] |
| . . . | Coronaviridae, e.g. avian infectious bronchitis virus [6] |
|
| C07K 14/17 | . . . . | Schweine-übertragbarer Gastroenteritis-Virus [6] |
| . . . . | Porcine transmissible gastroenteritis virus [6] |
|
| C07K 14/175 | . . . | Bunyaviridae, z.B. California-Enzephalitis-Virus, Rift-Valley-Fieber-Virus, Hantaan-Virus [6] |
| . . . | Bunyaviridae, e.g. California encephalitis virus, Rift valley fever virus, Hantaan virus [6] |
|
| C07K 14/18 | . . . | Togaviridae, z.B. Flavi-Virus, Pesti-Virus, Gelbfieber-Virus, Hepatitis-C-Virus, japanischer Enzephalitis-Virus [6] |
| . . . | Togaviridae, e.g. flavivirus, pestivirus, yellow fever virus, hepatitis C virus, japanese encephalitis virus [6] |
|
| C07K 14/185 | . . . . | Schweine-Cholera-Virus [6] |
| . . . . | Hog cholera virus [6] |
|
| C07K 14/19 | . . . . | Rubella-Virus [6] |
| . . . . | Rubella virus [6] |
|
| C07K 14/195 | | |
| C07K 14/20 | . . | aus Spirochaetales [O], z.B. Treponema, Leptospira [6] |
| . . | from Spirochaetales (O), e.g. Treponema, Leptospira [6] |
|
| C07K 14/205 | . . | aus Campylobacter [G] [6] |
| . . | from Campylobacter (G) [6] |
|
| C07K 14/21 | . . | aus Pseudomonadaceae [F] [6] |
| . . | from Pseudomonadaceae (F) [6] |
|
| C07K 14/215 | . . | aus Halobacteriaceae [F] [6] |
| . . | from Halobacteriaceae (F) [6] |
|
| C07K 14/22 | . . | aus Neisseriaceae [F], z.B. Acinetobacter [6] |
| . . | from Neisseriaceae (F), e.g. Acinetobacter [6] |
|
| C07K 14/225 | . . | aus Alcaligenes [G] [6] |
| . . | from Alcaligenes (G) [6] |
|
| C07K 14/23 | | . . | from Brucella (G) [6] |
|
| C07K 14/235 | . . | aus Bordetella [G] [6] |
| . . | from Bordetella (G) [6] |
|
| C07K 14/24 | . . | aus Enterobacteriaceae [F], z.B. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia [6] |
| . . | from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia [6] |
|
| C07K 14/245 | . . . | Escherichia [G] [6] |
| . . . | Escherichia (G) [6] |
|
| C07K 14/25 | | |
| C07K 14/255 | | |
| C07K 14/26 | | |
| C07K 14/265 | . . . | Enterobacter [G] [6] |
| . . . | Enterobacter (G) [6] |
|
| C07K 14/27 | | |
| C07K 14/275 | | |
| C07K 14/28 | . . | aus Vibrionaceae [F] [6] |
| . . | from Vibrionaceae (F) [6] |
|
| C07K 14/285 | . . | aus Pasteurellaceae [F], z.B. Haemophilus influenza [6] |
| . . | from Pasteurellaceae (F), e.g. Haemophilus influenza [6] |
|
| C07K 14/29 | . . | aus Rickettsien [O] [6] |
| . . | from Richettsiales (O) [6] |
|
| C07K 14/295 | . . | aus Chlamydien [O] [6] |
| . . | from Chlamydiales (O) [6] |
|
| C07K 14/30 | . . | aus Mycoplasmatales, z.B. Pleuropneumonia-ähnliche Organismen [pleuropneumonia-like organisms = PPLO] [6] |
| . . | from Mycoplasmatales, e.g. Pleuropneumonia-like organisms (PPLO) [6] |
|
| C07K 14/305 | . . | aus Micrococcaceae [F] [6] |
| . . | from Micrococcaceae (F) [6] |
|
| C07K 14/31 | . . . | aus Staphylococcus [G] [6] |
| . . . | from Staphylococcus (G) [6] |
|
| C07K 14/315 | . . | aus Streptococcus [G], z.B. Enterococci [6] |
| . . | from Streptococcus (G), e.g. Enterococci [6] |
|
| C07K 14/32 | | . . | from Bacillus (G) [6] |
|
| C07K 14/325 | . . . | Bacillus thuringiensis Kristall Peptid [delat-Endotoxin] [6] |
| . . . | Bacillus thuringiensis crystal peptide (delta-endotoxin) [6] |
|
| C07K 14/33 | . . | aus Chlostridium [G] [6] |
| . . | from Clostridium (G) [6] |
|
| C07K 14/335 | . . | aus Lactobacillus [G] [6] |
| . . | from Lactobacillus (G) [6] |
|
| C07K 14/34 | . . | aus Corynebacterium [G] [6] |
| . . | from Corynebacterium (G) [6] |
|
| C07K 14/345 | . . | aus Brevibacterium [G] [6] |
| . . | from Brevibacterium (G) [6] |
|
| C07K 14/35 | . . | aus Mycobacteriaceae [F] [6] |
| . . | from Mycobacteriaceae (F) [6] |
|
| C07K 14/355 | | . . | from Nocardia (G) [6] |
|
| C07K 14/36 | . . | aus Actinomyces; aus Streptomyces [G] [6] |
| . . | from Actinomyces; from Streptomyces (G) [6] |
|
| C07K 14/365 | . . | aus Actinoplanes [G] [6] |
| . . | from Actinoplanes (G) [6] |
|
| C07K 14/37 | | |
| C07K 14/375 | . . | aus Basidiomycetes [6] |
| . . | from Basidiomycetes [6] |
|
| C07K 14/38 | | |
| C07K 14/385 | | |
| C07K 14/39 | | |
| C07K 14/395 | . . . | aus Saccharomyces [6] |
| . . . | from Saccharomyces [6] |
|
| C07K 14/40 | | |
| C07K 14/405 | | |
| C07K 14/41 | | |
| C07K 14/415 | | |
| C07K 14/42 | . . | Lectine, z.B. Concanavalin, Phytohaemagglutinin [6] |
| . . | Lectins, e.g. concanavalin, phytohaemagglutinin [6] |
|
| C07K 14/425 | | |
| C07K 14/43 | | |
| C07K 14/435 | . | aus Tieren; aus Menschen [6] |
| . | from animals; from humans [6] |
|
| C07K 14/44 | | |
| C07K 14/445 | | |
| C07K 14/45 | | |
| C07K 14/455 | | |
| C07K 14/46 | | |
| C07K 14/465 | | |
| C07K 14/47 | . . . | aus Säugetieren [6] |
| |
| C07K 14/475 | . . | Wachstumsfaktoren; Wachstumsregulatoren [6] |
| . . | Growth factors; Growth regulators [6] |
|
| C07K 14/48 | . . . | Nerven-Wachstumsfaktor [nerve growth factor = NGF] [6] |
| . . . | Nerve growth factor (NGF) [6] |
|
| C07K 14/485 | . . . | Epidermaler Wachstumsfaktor [epidermal growth factor = EGF] [Urogastron] [6] |
| . . . | Epidermal growth factor (EGF) (urogastrone) [6] |
|
| C07K 14/49 | . . . | Plättchen-Wachstumsfaktor [platelet-derived growth factor = PDGF] [6] |
| . . . | Platelet-derived growth factor (PDGF) [6] |
|
| C07K 14/495 | . . . | Transformierender Wachstumsfaktor [transforming growth factor = TGF] [6] |
| . . . | Transforming growth factor (TGF) [6] |
|
| C07K 14/50 | . . . | Fibroblasten-Wachstumsfaktor [fibroblast growth factor = FGF] [6] |
| . . . | Fibroblast growth factor (FGF) [6] |
|
| C07K 14/505 | . . . | Erythropoietin [EPO] [6] |
| . . . | Erythropoietin (EPO) [6] |
|
| C07K 14/51 | . . . | Knochen-morphogener Faktor; Osteogenin; Osteogenischer Faktor; Knochen-induzierender Faktor [6] |
| . . . | Bone morphogenic factor; Osteogenin; Osteogenic factor; Bone-inducing factor [6] |
|
| C07K 14/515 | . . . | Angiogenischer Faktor; Angiogenin [6] |
| . . . | Angiogenic factor; Angiogenin [6] |
|
| C07K 14/52 | . . | Cytokine; Lymphokine; Interferone [6] |
| . . | Cytokines; Lymphokines; Interferons [6] |
|
| C07K 14/525 | . . . | Tumor-Nekrose Faktor [TNF] [6] |
| . . . | Tumour necrosis factor (TNF) [6] |
|
| C07K 14/53 | . . . | Kolonie-stimulierender Faktor [colony-stimulating factor = CSF] [6] |
| . . . | Colony-stimulating factor (CSF) [6] |
|
| C07K 14/535 | . . . . | Granulocyten CSF; Granulocyten-Makrophagen CSF [6] |
| . . . . | Granulocyte CSF; Granulocyte-macrophage CSF [6] |
|
| C07K 14/54 | . . . | Interleukine [IL] [6] |
| . . . | Interleukins (IL) [6] |
|
| C07K 14/545 | | |
| C07K 14/55 | | |
| C07K 14/555 | . . . | Interferone [IFN] [6] |
| . . . | Interferons (IFN) [6] |
|
| C07K 14/56 | | |
| C07K 14/565 | | |
| C07K 14/57 | | |
| C07K 14/575 | | |
| C07K 14/58 | . . . | Atriale natriuretische Faktoren; Atriopeptin; Atriales natriuretisches Peptid [ANP]; Cardionatrin; Cardiodilatin [6] |
| . . . | Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide (ANP); Cardionatrin; Cardiodilatin [6] |
|
| C07K 14/585 | | |
| C07K 14/59 | . . . | Follikel-stimulierendes Hormon [FSH]; Choriongonadotropine, z.B. HCG; Luteinisierendes Hormon [LH]; Thyreoid-stimulierendes Hormon [TSH] [Thyreotropin] [6] |
| . . . | Follicle-stimulating hormone (FSH); Chorionic gonadotropins, e.g. HCG; Luteinising hormone (LH); Thyroid-stimulating hormone (TSH) [6] |
|
| C07K 14/595 | . . . | Gastrine; Cholecystokinine [CCK] [6] |
| . . . | Gastrins; Cholecystokinins (CCK) [6] |
|
| C07K 14/60 | . . . | Wachstumshormon-freisetzender Faktor [growth hormone-releasing factor = GH-RF] [Somatoliberin] [6] |
| . . . | Growth hormone-releasing factor (GH-RF) (Somatoliberin) [6] |
|
| C07K 14/605 | | |
| C07K 14/61 | . . . | Wachstumshormone [growth hormone = GH] [Somatotropin] [6] |
| . . . | Growth hormone (GH) (Somatotropin) [6] |
|
| C07K 14/615 | . . . . | Extraktion aus natürlichen Quellen [6] |
| . . . . | Extraction from natural sources [6] |
|
| C07K 14/62 | | |
| C07K 14/625 | . . . . | Extraktion aus natürlichen Quellen [6] |
| . . . . | Extraction from natural sources [6] |
|
| C07K 14/63 | | |
| C07K 14/635 | . . . | Parathyreoidea-Hormon [Parathormon]; verwandte Peptide [6] |
| . . . | Parathyroid hormone (parathormone); Parathyroid hormone-related peptides [6] |
|
| C07K 14/64 | | |
| C07K 14/645 | | |
| C07K 14/65 | . . . | Insulinartige Wachstumsfaktoren [insulin-like growth factors = Somatomedine], z.B. IGF-1, IGF-2 [6] |
| . . . | Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2 [6] |
|
| C07K 14/655 | | |
| C07K 14/66 | | |
| C07K 14/665 | . . | abgeleitet von Pro-Opiomelanocortin, Pro-Enkephalin oder Pro-Dynorphin [6] |
| . . | derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin [6] |
|
| C07K 14/67 | . . . | Lipotropine, z.B. β - oder gamma-Lipotropin [6] |
| . . . | Lipotropins, e.g. beta- or gamma-lipotropin [6] |
|
| C07K 14/675 | | . . . | Beta-endorphins [6] |
|
| C07K 14/68 | . . . | Melanozyten-stimulierendes Hormon [MSH] [6] |
| . . . | Melanocyte-stimulating hormone (MSH) [6] |
|
| C07K 14/685 | . . . . | α -Melanotropin [6] |
| . . . . | Alpha-melanotropin [6] |
|
| C07K 14/69 | . . . . | β -Melanotropin [6] |
| . . . . | Beta-melanotropin [6] |
|
| C07K 14/695 | . . . | Corticotropin [ACTH] [6] |
| . . . | Corticotropin (ACTH) [6] |
|
| C07K 14/70 | | |
| C07K 14/705 | . . | Rezeptoren; Zelloberflächen-Antigene; Zelloberflächen-Determinanten [6] |
| . . | Receptors; Cell surface antigens; Cell surface determinants [6] |
|
| C07K 14/71 | . . . | für Wachstumsfaktoren; für Wachstumsregulatoren [6] |
| . . . | for growth factors; for growth regulators [6] |
|
| C07K 14/715 | . . . | für Cytokine; für Lymphokine; für Interferone [6] |
| . . . | for cytokines; for lymphokines; for interferons [6] |
|
| C07K 14/72 | | |
| C07K 14/725 | . . . | T-Zell-Rezeptoren [6] |
| . . . | T-cell receptors [6] |
|
| C07K 14/73 | | |
| C07K 14/735 | | |
| C07K 14/74 | . . . | Major-Histokompabilitätskomplex [major histocompatibility complex = MHC] [6] |
| . . . | Major histocompatibility complex (MHC) [6] |
|
| C07K 14/745 | . . | Blutgerinnungs- oder Fibrinolyse-Faktoren [6] |
| . . | Blood coagulation or fibrinolysis factors [6] |
|
| C07K 14/75 | | |
| C07K 14/755 | | |
| C07K 14/76 | | |
| C07K 14/765 | . . . | Serumalbumin, z.B. HSA [6] |
| . . . | Serum albumin, e.g. HSA [6] |
|
| C07K 14/77 | . . . | Ovalbumin [Eialbumin] [6] |
| |
| C07K 14/775 | | |
| C07K 14/78 | . . | Bindegewebspeptide, z.B. Kollagen, Elastin, Laminin, Fibronectin, Vitronectin, kälteunlösliches Globulin [cold insoluble globulin = CIG] [6] |
| . . | Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG) [6] |
|
| C07K 14/785 | . . | Alveolare oberflächenaktive Peptide; Pulmonare oberflächenaktive Peptide [6] |
| . . | Alveolar surfactant peptides; Pulmonary surfactant peptides [6] |
|
| C07K 14/79 | . . | Transferrine, z.B. Lactoferrine, Ovotransferrine [6] |
| . . | Transferrins, e.g. lactoferrins, ovotransferrins [6] |
|
| C07K 14/795 | . | Porphyrin- oder Corrinringe enthaltende Peptide [6] |
| . | Porphyrin- or corrin-ring-containing peptides [6] |
|
| C07K 14/80 | | |
| C07K 14/805 | . . | Haemoglobine; Myoglobine [6] |
| . . | Haemoglobins; Myoglobins [6] |
|
| C07K 14/81 | . | Protease-Inhibitoren [6] |
| . | Protease inhibitors [6] |
|
| C07K 14/815 | . . | aus Blutegeln, z.B. Hirudin, Eglin [6] |
| . . | from leeches, e.g. hirudin, eglin [6] |
|
| C07K 14/82 | . | Translationsprodukte aus Oncogenen [6] |
| . | Translation products from oncogenes [6] |
|
| C07K 14/825 | | |
| C07K 16/00 | Immunglobuline, z.B. monoclonale oder polyclonale Antikörper [6] | Immunoglobulins, e.g. monoclonal or polyclonal antibodies [6] |
| C07K 16/02 | | |
| C07K 16/04 | | |
| C07K 16/06 | | |
| C07K 16/08 | . | gegen Stoffe aus Viren [6] |
| . | against material from viruses [6] |
|
| C07K 16/10 | | |
| C07K 16/12 | . | gegen Stoffe aus Bakterien [6] |
| . | against material from bacteria [6] |
|
| C07K 16/14 | . | gegen Stoffe aus Pilzen, Algen oder Flechten [6] |
| . | against material from fungi, algae or lichens [6] |
|
| C07K 16/16 | . | gegen Stoffe aus Pflanzen [6] |
| . | against material from plants [6] |
|
| C07K 16/18 | . | gegen Stoffe aus Tieren oder Menschen [6] |
| . | against material from animals or humans [6] |
|
| C07K 16/20 | | |
| C07K 16/22 | . . | gegen Wachstumsfaktoren [6] |
| . . | against growth factors [6] |
|
| C07K 16/24 | . . | gegen Cytokine, Lymphokine oder Interferone [6] |
| . . | against cytokines, lymphokines or interferons [6] |
|
| C07K 16/26 | | |
| C07K 16/28 | . . | gegen Rezeptoren, Zelloberflächen-Antigene oder Zelloberflächen-Determinanten [6] |
| . . | against receptors, cell surface antigens or cell surface determinants [6] |
|
| C07K 16/30 | . . . | aus Tumorzellen [6] |
| . . . | from tumour cells [6] |
|
| C07K 16/32 | . . | gegen Tranlationsprodukte aus Oncogenen [6] |
| . . | against translation products from oncogenes [6] |
|
| C07K 16/34 | . . | gegen Blutgruppen-Antigene [6] |
| . . | against blood group antigens [6] |
|
| C07K 16/36 | . . | gegen Blutgerinnungs-Faktoren [6] |
| . . | against blood coagulation factors [6] |
|
| C07K 16/38 | . | gegen Protease-Inhibitoren peptidischer Struktur [6] |
| . | against protease inhibitors of peptide structure [6] |
|
| C07K 16/40 | | |
| C07K 16/42 | . | gegen Immunglobuline [Anti-idiotypische Antikörper] [6] |
| . | against immunoglobulins (anti-idiotypic antibodies) [6] |
|
| C07K 16/44 | . | gegen Stoffe, die nicht anderweitig vorgesehen sind [6] |
| . | against material not provided for elsewhere [6] |
|
| C07K 16/46 | . | Hybrid-Immunglobuline (Hybride eines Immunglobulins mit einem Peptid, das kein Immunglobulin ist C07K 19/00) [6] |
| . | Hybrid immunoglobulins (hybrids of an immunoglobulin with a peptide not being an immunoglobulin C07K 19/00) [6] |
|
| C07K 17/00 | Trägergebundene oder immobilisierte Peptide; deren Herstellung [4] | Carrier-bound or immobilised peptides; Preparation thereof [4] |
| C07K 17/02 | . | an oder in einem organischen Träger immobilisierte Peptide [4] |
| . | Peptides being immobilised on, or in, an organic carrier [4] |
|
| C07K 17/04 | . . | in den Träger, z.B. Gel, Hohlfaser, eingeschlossen [4] |
| . . | entrapped within the carrier, e.g. gel, hollow fibre [4] |
|
| C07K 17/06 | . . | über ein Brückenglied an den Träger gebunden [4] |
| . . | attached to the carrier via a bridging agent [4] |
|
| C07K 17/08 | . . | synthetisches Polymer als Träger [4] |
| . . | the carrier being a synthetic polymer [4] |
|
| C07K 17/10 | . . | Kohlenhydrat als Träger [4] |
| . . | the carrier being a carbohydrate [4] |
|
| C07K 17/12 | . . . | Cellulose oder deren Derivate [4] |
| . . . | Cellulose or derivatives thereof [4] |
|
| C07K 17/14 | . | an oder in einem anorganischen Träger immobilisierte Peptide |
| . | Peptides being immobilised on, or in, an inorganic carrier [4] |
|
| C07K 19/00 | Hybridpeptide (Hybrid-Immunglobuline, ausschließlich aus Immunglobulinen zusammengesetzt C07K 16/46) [6] | Hybrid peptides (hybrid immunoglobulins composed solely of immunoglobulins C07K 16/46) [6] |